- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 40FR12B Initial registration of securities (Canada)
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
- 99.9 EX-99.9
- 99.10 EX-99.10
- 99.11 EX-99.11
- 99.12 EX-99.12
- 99.13 EX-99.13
- 99.14 EX-99.14
- 99.15 EX-99.15
- 99.16 EX-99.16
- 99.17 EX-99.17
- 99.18 EX-99.18
- 99.19 EX-99.19
- 99.21 EX-99.21
- 99.22 EX-99.22
- 99.23 EX-99.23
- 99.24 EX-99.24
- 99.25 EX-99.25
- 99.26 EX-99.26
- 99.27 EX-99.27
- 99.28 EX-99.28
- 99.29 EX-99.29
- 99.31 EX-99.31
- 99.32 EX-99.32
- 99.33 EX-99.33
- 99.34 EX-99.34
- 99.35 EX-99.35
- 99.36 EX-99.36
- 99.37 EX-99.37
- 99.38 EX-99.38
- 99.39 EX-99.39
- 99.40 EX-99.40
- 99.41 EX-99.41
- 99.42 EX-99.42
- 99.43 EX-99.43
- 99.44 EX-99.44
- 99.45 EX-99.45
- 99.46 EX-99.46
- 99.47 EX-99.47
- 99.48 EX-99.48
- 99.49 EX-99.49
- 99.50 EX-99.50
- 99.51 EX-99.51
- 99.52 EX-99.52
- 99.53 EX-99.53
- 99.54 EX-99.54
- 99.55 EX-99.55
- 99.56 EX-99.56
- 99.57 EX-99.57
- 99.58 EX-99.58
- 99.59 EX-99.59
- 99.60 EX-99.60
- 99.61 EX-99.61
- 99.62 EX-99.62
- 99.63 EX-99.63
- 99.64 EX-99.64
- 99.65 EX-99.65
- 99.66 EX-99.66
- 99.67 EX-99.67
- 99.68 EX-99.68
- 99.69 EX-99.69
- 99.70 EX-99.70
- 99.71 EX-99.71
- 99.72 EX-99.72
- 99.73 EX-99.73
- 99.74 EX-99.74
- 99.75 EX-99.75
- 99.76 EX-99.76
- 99.77 EX-99.77
- 99.78 EX-99.78
- 99.79 EX-99.79
- 99.80 EX-99.80
- 99.81 EX-99.81
- 99.82 EX-99.82
- 99.83 EX-99.83
- 99.84 EX-99.84
- 99.85 EX-99.85
- 99.86 EX-99.86
- 99.87 EX-99.87
- 99.88 EX-99.88
- 99.89 EX-99.89
- 99.90 EX-99.90
- 99.91 EX-99.91
- 99.92 EX-99.92
- 99.93 EX-99.93
- 99.94 EX-99.94
- 99.95 EX-99.95
- 99.96 EX-99.96
- 99.97 EX-99.97
- 99.98 EX-99.98
- 99.99 EX-99.99
- 99.100 EX-99.100
- 99.101 EX-99.101
- 99.102 EX-99.102
- 99.103 EX-99.103
- 99.104 EX-99.104
- 99.105 EX-99.105
- 99.106 EX-99.106
- 99.108 EX-99.108
- 99.109 EX-99.109
- 99.110 EX-99.110
- 99.111 EX-99.111
- 99.112 EX-99.112
- 99.113 EX-99.113
- 99.114 EX-99.114
- 99.115 EX-99.115
- 99.116 EX-99.116
- 99.117 EX-99.117
- 99.118 EX-99.118
- 99.119 EX-99.119
- 99.120 EX-99.120
- 99.121 EX-99.121
- 99.122 EX-99.122
- 99.123 EX-99.123
- 99.124 EX-99.124
- 99.125 EX-99.125
- 99.126 EX-99.126
- 99.127 EX-99.127
- 99.128 EX-99.128
- 99.129 EX-99.129
- 99.130 EX-99.130
Exhibit 99.105
VIA SEDAR
June 19, 2019
Alberta Securities Commission
Autorité des marchés financiers (Québec)
British Columbia Securities Commission
Manitoba Securities Commission
New Brunswick Securities Commission
Service Newfoundland and Labrador
Nova Scotia Securities Commission
Ontario Securities Commission
Prince Edward Island Securities Office
Saskatchewan Financial Services Commission
RE : | Report of Voting Results pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (« NI 51-102 ») |
Following the Annual and Special Meeting of Shareholders of Prometic Life Sciences Inc. (the “Corporation”) held on June 19, 2019 (the “Meeting”), and in accordance with section 11.3 of NI 51-102, continuous disclosure obligations, we hereby advise you of the matters voted upon at the Meeting and the voting results, the whole as detailed in the Management Information Circular of the Corporation dated May 7, 2019 (the “Circular”). According to the scrutineers’ report, the shareholders present at the meeting, in person or by proxy, represented 16,792,591,957 Common Shares, or 81.04% of the 20,720,605,452 shares outstanding on May 10, 2019, the record date for the Meeting.
Election of Directors of the Corporation
The seven (7) nominees set forth in the Circular were elected as directors of the Corporation pursuant to a vote conducted by a show of hands:
Name of Nominee | For | Withheld | ||||||||||||||
Votes | % | Votes | % | |||||||||||||
Simon Geoffrey Best | 16,728,666,243 | 99.83 | 27,934,841 | 0.17 | ||||||||||||
Stefan Clulow | 16,734,303,991 | 99.87 | 22,297,093 | 0.13 | ||||||||||||
Kenneth Galbraith | 16,739,015,483 | 99.90 | 17,585,601 | 0.10 | ||||||||||||
Gary J. Bridger | 16,739,454,207 | 99.90 | 17,146,877 | 0.10 | ||||||||||||
Neil A. Klompas | 16,740,432,806 | 99.90 | 16,168,278 | 0.10 | ||||||||||||
Zachary Newton | 16,737,582,720 | 99.89 | 19,018,364 | 0.11 | ||||||||||||
Timothy Steven Wach | 16,739,799,987 | 99.90 | 16,801,097 | 0.10 |
Appointment of Auditors
PricewaterhouseCoopers LLP were appointed auditors of the Corporation to hold office until the next annual meeting of shareholders, and the board of directors was authorized to fix the auditors’ remuneration pursuant to a vote conducted by a show of hands.
For | Withheld | |||||
Votes | % | Votes | % | |||
16,769,856,163 | 99.89 | 18,648,447 | 0.11 |
Omnibus Incentive Plan
The Omnibus Incentive Plan was approved pursuant to a vote conducted by ballot:
For | Against | |||||
Votes | % | Votes | % | |||
16,723,471,116 | 99.79 | 35,707,697 | 0.21 |
Consolidation of the Outstanding Common Shares of the Corporation
The amendment to the articles of the Corporation to effect a consolidation of all of the issued and outstanding common shares of the Corporation was approved pursuant to a vote conducted by ballot, on the basis of a consolidation ratio to be selected by the Board within a range between seven hundred fifty (750) pre-consolidation Common Shares for one (1) post-consolidation Common Share and one thousand two hundred fifty (1250) pre-consolidation Common Shares for one (1) post-consolidation Common Share, effective as at the discretion of the Board and subject to TSX approval, provided that such date shall be before June 20, 2020.
For | Against | |||||
Votes | % | Votes | % | |||
16,730,151,507 | 99.83 | 28,568,061 | 0.17 |
Prometic Life Sciences Inc. |
(s) Patrick Sartore |
Patrick Sartore |
Chief Operating Officer, North America, |
Chief Legal Officer and Corporate Secretary |